PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 176 filers reported holding PDL BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KESTREL INVESTMENT MANAGEMENT CORP | 1,465,000 | $3,853,000 | 1.56% |
| SMH CAPITAL ADVISORS INC | 93,708 | $246,000 | 0.42% |
| West Family Investments, Inc. | 627,800 | $1,651,000 | 0.39% |
| KENNEDY CAPITAL MANAGEMENT LLC | 7,082,858 | $18,628,000 | 0.35% |
| ARMISTICE CAPITAL, LLC | 1,800,000 | $4,734,000 | 0.28% |
| BRANDES INVESTMENT PARTNERS, LP | 3,936,719 | $10,354,000 | 0.23% |
| ROCKY MOUNTAIN ADVISERS, LLC | 14,300 | $38,000 | 0.13% |
| Zebra Capital Management LLC | 74,695 | $196,000 | 0.09% |
| Connor, Clark & Lunn Investment Management Ltd. | 5,968,105 | $15,696,000 | 0.09% |
| CREDIT AGRICOLE S A | 471,644 | $1,240,000 | 0.06% |